CTI BIOPHARMA Trademark

Trademark Overview


On Thursday, May 15, 2014, a trademark application was filed for CTI BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the CTI BIOPHARMA trademark a serial number of 86282220. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, March 24, 2023. This trademark is owned by Cell Therapeutics, Inc.. The CTI BIOPHARMA trademark is filed in the Pharmaceutical Products, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:

Conducting seminars, classes, workshops, and training in the fields of pharmaceutical products and the treatment of medical disorders, the life sciences, clinical trials, health, medicine, oncology, hematology, cancer, and genetic disorders, and providing course materials in connection therewith; Online publications in the nature of articles, journals, and newsletters in the fields of pharmaceuticals and the treatment of medical disorders, the life sciences, clinical trials, health, medicine, oncology, hematology, cancer, and genetic disorders

Pharmaceutical preparations and substances for the treatment of cancer and for use in chemotherapy treatment; Pharmaceutical preparations and substances for the treatment of immunological, oncological, inflammatory and infectious diseases and disorders; Pharmaceutical preparations used for the treatment of conditions secondary to the oncologic, immunological and inflammatory diseases; Pharmaceutical preparations and substances for the management and treatment of pain accompanying either the disease process or the associated treatment regimens

Research, development, engineering, testing, product evaluation, and inspection in the field of pharmaceutical preparations and products; Pharmaceutical research and development; Providing technical consultation in the field of pharmaceutical product research and development; Medical and scientific research, namely, conducting clinical trials for others for pharmaceutical preparations used for the treatment of cancer, immunological, inflammatory and infectious diseases, and pain; Scientific research, consulting, and advice in the fields of biotechnology, pharmaceutical research and development, and the life sciences; Pharmaceutical, medical and laboratory research services in the fields of pharmaceuticals, cancer, genetic disorders, and the life sciences; Providing medical testing services for research purposes and medical and scientific research information in the fields of pharmaceuticals, the life sciences, clinical trials, medicine, oncology, hematology, cancer, disease classificat...
cti biopharma

General Information


Serial Number86282220
Word MarkCTI BIOPHARMA
Filing DateThursday, May 15, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, March 24, 2023
Registration Number5166752
Registration DateTuesday, March 21, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 15, 2015

Trademark Statements


Goods and ServicesConducting seminars, classes, workshops, and training in the fields of pharmaceutical products and the treatment of medical disorders, the life sciences, clinical trials, health, medicine, oncology, hematology, cancer, and genetic disorders, and providing course materials in connection therewith; Online publications in the nature of articles, journals, and newsletters in the fields of pharmaceuticals and the treatment of medical disorders, the life sciences, clinical trials, health, medicine, oncology, hematology, cancer, and genetic disorders
Goods and ServicesPharmaceutical preparations and substances for the treatment of cancer and for use in chemotherapy treatment; Pharmaceutical preparations and substances for the treatment of immunological, oncological, inflammatory and infectious diseases and disorders; Pharmaceutical preparations used for the treatment of conditions secondary to the oncologic, immunological and inflammatory diseases; Pharmaceutical preparations and substances for the management and treatment of pain accompanying either the disease process or the associated treatment regimens
Pseudo MarkCTI BIO PHARMA
Disclaimer with Predetermined Text"BIOPHARMA"
Goods and ServicesResearch, development, engineering, testing, product evaluation, and inspection in the field of pharmaceutical preparations and products; Pharmaceutical research and development; Providing technical consultation in the field of pharmaceutical product research and development; Medical and scientific research, namely, conducting clinical trials for others for pharmaceutical preparations used for the treatment of cancer, immunological, inflammatory and infectious diseases, and pain; Scientific research, consulting, and advice in the fields of biotechnology, pharmaceutical research and development, and the life sciences; Pharmaceutical, medical and laboratory research services in the fields of pharmaceuticals, cancer, genetic disorders, and the life sciences; Providing medical testing services for research purposes and medical and scientific research information in the fields of pharmaceuticals, the life sciences, clinical trials, medicine, oncology, hematology, cancer, disease classification, and genetic disorders; and consultation related to the foregoing

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 28, 2014
Primary Code005
First Use Anywhere DateFriday, December 18, 2015
First Use In Commerce DateFriday, December 18, 2015

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateWednesday, May 28, 2014
Primary Code041
First Use Anywhere DateSaturday, May 31, 2014
First Use In Commerce DateSaturday, May 31, 2014

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 28, 2014
Primary Code042
First Use Anywhere DateSaturday, May 31, 2014
First Use In Commerce DateSaturday, May 31, 2014

Trademark Owner History


Party NameCTI BIOPHARMA CORP.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSEATTLE, WA 98121

Party NameCTI BIOPHARMA CORP.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSEATTLE, WA 98121

Party NameCTI BIOPHARMA CORP.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressSEATTLE, WA 98121

Party NameCell Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98121

Trademark Events


Event DateEvent Description
Friday, March 24, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, March 24, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, March 24, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, September 13, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, March 21, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, June 12, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Thursday, May 14, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 14, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 6, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 6, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 6, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, May 6, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 6, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 6, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 21, 2017REGISTERED-PRINCIPAL REGISTER
Thursday, February 16, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, February 15, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, January 25, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 25, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 19, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 19, 2017TEAS EXTENSION RECEIVED
Monday, September 26, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 26, 2016NON-FINAL ACTION E-MAILED
Monday, September 26, 2016SU - NON-FINAL ACTION - WRITTEN
Friday, September 2, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 1, 2016STATEMENT OF USE PROCESSING COMPLETE
Monday, August 8, 2016USE AMENDMENT FILED
Thursday, September 1, 2016SOU EXTENSION 1 GRANTED
Monday, August 8, 2016SOU EXTENSION 1 FILED
Wednesday, August 31, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 8, 2016TEAS EXTENSION RECEIVED
Monday, August 8, 2016TEAS STATEMENT OF USE RECEIVED
Friday, May 6, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 6, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 9, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 15, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 15, 2015PUBLISHED FOR OPPOSITION
Wednesday, November 25, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 6, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, October 26, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 20, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 19, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 19, 2015TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, April 29, 2015NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, April 29, 2015FINAL REFUSAL E-MAILED
Wednesday, April 29, 2015FINAL REFUSAL WRITTEN
Wednesday, March 11, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 11, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 6, 2015ASSIGNED TO LIE
Thursday, February 26, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, August 31, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, August 31, 2014NON-FINAL ACTION E-MAILED
Sunday, August 31, 2014NON-FINAL ACTION WRITTEN
Sunday, August 31, 2014ASSIGNED TO EXAMINER
Wednesday, July 2, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, May 29, 2014NOTICE OF PSEUDO MARK E-MAILED
Wednesday, May 28, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 19, 2014NEW APPLICATION ENTERED